<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201006048947N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-10-21</date_registration>
      <primary_sponsor>Jahrom University of Medical Sciences</primary_sponsor>
      <public_title>The effect of ondansetron on the prevention of hypotension after spinal anesthesia</public_title>
      <acronym></acronym>
      <scientific_title>Effect of intravenous ondansetron in comparison with placebo on prevention of hypotension after spinal anesthesia in patients undergoing lower limb orthopedic surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-10-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/51450</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: This clinical trial is performed in a simple randomization with individual randomization unit and in order to obtain equal sample sizes in the two groups, it is performed in a restricted randomization and by the method of random allocation rule, so that first the total sample size is determined (for example, 100 samples) and then we divide the set into group A and the set into group B, then 50 balls for intervention A and 50 balls for intervention B are placed in the lottery, then the balls are randomly drawn out without replacement. It is taken out of the container and the created sequence is recorded.To hide random allocation, opaque sealed envelopes with random sequences are used. After determining the random sequence, a number of envelopes are prepared and random sequences are recorded on the card and placed in the envelope. Envelopes are numbered sequentially, and when collecting samples, the envelopes are opened one by one and the assigned group is identified, Blinding description: Before performing spinal anesthesia, an anesthesiologist inserts syringes, half of which contain ondansetron and the other half containing placebo, and the syringes are numbered, so neither the participant nor the clinical caregiver and the researcher knows which syringe is placebo and which one is the medicine.</study_design>
      <phase>3</phase>
      <hc_freetext>Hypotention induced by spinal anesthesia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients are among the candidates for orthopedic surgery for spinal anesthesia who have no contraindications to spinal anesthesia and have been fasting for at least 8 hours receiving 300 mg of normal saline or ringer and 4 mg of ondansetron intravenously before spinal anesthesia during 30 secends. Intervention 2: Control group: Intervention group: Patients are among the candidates for orthopedic surgery for spinal anesthesia who have no contraindications to spinal anesthesia and have been fasting for at least 8 hours receiving 300 mg of normal saline or ringer and 4 mg of plasbo  intravenously before spinal anesthesia during 30 secends.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data will be shareable

When:
Access starts 6 months after the results are published

To whom:
Only for researchers working in academic institutions

Conditions:
Only for researchers working in academic institutions

Where to obtain:
To the researcher named Nasim Nabizadeh by calling 00989364731778
Or the postal address of Jahrom, Helal Ahmar Street, 26th Alley with postal code 7413718849
Or email nassimnabizadeh@gmail.com

How to obtain:
This data is available 6 months after the publication of the results and the applicant will have access to it up to one week after the announcement of the request.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nasim Nabizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 26, Helal Ahmar avenue</address>
        <city>Jahrom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7413718849</zip>
        <telephone>+98 54 0022 3275</telephone>
        <email>Nassimnabizadeh@gmail.com</email>
        <affiliation>Jahrom University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nasim Nabizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 26, Helal Ahmar avenue</address>
        <city>Jahrom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7413718849</zip>
        <telephone>+98 54 0022 3275</telephone>
        <email>Nassimnabizadeh@gmail.com</email>
        <affiliation>Jahrom University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Candidates for orthopedic surgery by spinal anesthesia at Peymanieh Hospital in Jahrom
Satisfaction of the person to participate in the study
age between 18 to 65 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with hypertension
weight more than 100 kg
motion sickness
cardiac and liver desease and migrain
allery to ondansetron drugs
using any drugs that change blood pressure or hear rate and any drugs that effects by serotonin receptor</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients are among the candidates for orthopedic surgery for spinal anesthesia who have no contraindications to spinal anesthesia and have been fasting for at least 8 hours receiving 300 mg of normal saline or ringer and 4 mg of ondansetron intravenously before spinal anesthesia during 30 secends.</i_keyword>
      <i_keyword>Control group: Intervention group: Patients are among the candidates for orthopedic surgery for spinal anesthesia who have no contraindications to spinal anesthesia and have been fasting for at least 8 hours receiving 300 mg of normal saline or ringer and 4 mg of plasbo  intravenously before spinal anesthesia during 30 secends.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Percentage of people with hypotension. Timepoint: Blood pressure measurement during the first 10 minutes, every 3 minutes and then every 5 minutes until the end of 30 minutes of spinal anesthesia. Method of measurement: Measurement with heart  monitoring device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Percentage of people with decreased heart rate. Timepoint: during the first 10 minutes, every 3 minutes and then every 5 minutes until the end of 30 minutes of spinal anesthesia. Method of measurement: Measuring heart rate with a heart rate monitor.</sec_outcome>
      <sec_outcome>Percentage of people with pruritus  after spinal anesthesia. Timepoint: Every 10 minutes after spinal anesthesia. Method of measurement: by asking the patient.</sec_outcome>
      <sec_outcome>Percentage of people with nausea after spinal anesthesia. Timepoint: Every 10 minutes after spinal anesthesia. Method of measurement: by asking the patient.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Jahrom University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-01-22</approval_date>
        <contact_name>Ethics committee of Jahrom University of Medical Sciences</contact_name>
        <contact_address>Jahrom University Of Medical science; Motahari street Jahrom Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
